Fortress Biotech, Inc. (FBIO)
2.93
+0.06
(+2.09%)
USD |
NASDAQ |
Aug 24, 16:00
2.93
0.00 (0.00%)
After-Hours: 20:00
Fortress Biotech Shareholders Equity (Quarterly) : 164.14M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 164.14M |
| March 31, 2026 | 162.21M |
| December 31, 2025 | 49.87M |
| September 30, 2025 | 55.86M |
| June 30, 2025 | 43.92M |
| March 31, 2025 | 22.25M |
| December 31, 2024 | 22.74M |
| September 30, 2024 | 21.16M |
| June 30, 2024 | 17.88M |
| March 31, 2024 | 23.02M |
| December 31, 2023 | 22.54M |
| September 30, 2023 | 16.67M |
| June 30, 2023 | 18.51M |
| March 31, 2023 | 37.80M |
| December 31, 2022 | 41.72M |
| September 30, 2022 | 61.67M |
| June 30, 2022 | 77.22M |
| March 31, 2022 | 97.86M |
| December 31, 2021 | 108.67M |
| September 30, 2021 | 92.66M |
| June 30, 2021 | 108.28M |
| March 31, 2021 | 105.90M |
| December 31, 2020 | 100.34M |
| September 30, 2020 | 97.11M |
| June 30, 2020 | 60.48M |
| Date | Value |
|---|---|
| March 31, 2020 | 37.23M |
| December 31, 2019 | 26.22M |
| September 30, 2019 | 25.80M |
| June 30, 2019 | 31.87M |
| March 31, 2019 | 20.82M |
| December 31, 2018 | |
| September 30, 2018 | 37.77M |
| June 30, 2018 | 43.93M |
| March 31, 2018 | 41.65M |
| December 31, 2017 | 52.57M |
| September 30, 2017 | 36.94M |
| June 30, 2017 | 72.27M |
| March 31, 2017 | 47.75M |
| December 31, 2016 | 38.50M |
| September 30, 2016 | 36.63M |
| June 30, 2016 | 35.34M |
| March 31, 2016 | 44.56M |
| December 31, 2015 | 56.85M |
| September 30, 2015 | 53.61M |
| June 30, 2015 | 55.88M |
| March 31, 2015 | 60.15M |
| December 31, 2014 | 70.52M |
| September 30, 2014 | 69.26M |
| June 30, 2014 | 72.37M |
| March 31, 2014 | 75.49M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | 4.371M |
| Ironwood Pharmaceuticals, Inc. | -161.84M |
| Kura Oncology, Inc. | 48.43M |
| Spero Therapeutics, Inc. | 44.20M |
| Cue Biopharma, Inc. | 2.31M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 316.72M |
| Total Liabilities (Quarterly) | 110.63M |
| Debt to Equity Ratio | 0.3248 |
| Current Ratio | 3.959 |
| Net Debt Paydown Yield | 4.10% |